CLINICAL_TRIALS trial_result · 2010-12-29

Clinical Trial Update: A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

A Phase 2 trial evaluating tolerability of AZD9668 in chronic obstructive pulmonary disease has completed. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2010-12-29